logo
logo

You're viewing 1 of thousands of funding rounds tracked monthly

Members receive AI-scored leads and instant alerts when companies matching their criteria raise capital. Search all rounds by stage, amount, and investor.

Metsera, Inc. raised $215 million in a Series B funding round led by Wellington Management and Venrock Healthcare Capital Partners to advance its clinical-stage portfolio of peptide therapies.

Metsera, Inc. raised $215 million in a Series B funding round led by Wellington Management and Venrock Healthcare Capital Partners to advance its clinical-stage portfolio of peptide therapies.

11/13/24, 12:06 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgnew york
Money raised
$215 million
Industry
biotechnology
health care
Round Type
series b
Investors
Sym Biosis, Newpath Partners, Soft Bank Vision Fund 2, Gv, Alpha Wave Ventures, Arch Venture Partners, Ra Capital Management, Deep Track Capital, Viking Global Investors, T. Rowe Price Investment Management, Inc., T. Rowe Price Associates, Inc., Janus Henderson Investors, Fidelity Management & Research Company, Venrock Healthcare Capital Partners, Wellington Management
Metsera, Inc. has successfully closed a $215 million Series B financing round to further accelerate its innovative portfolio aimed at treating obesity and metabolic diseases. The round was backed by prominent investors including Wellington Management and Venrock Healthcare Capital Partners, alongside several new and existing investors.

Company Info

Company
Metsera
Location
new york, new york, united states
Additional Info
Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape.
Test Drive Fundz

Try Fundz Free — See How Real-Time Signal Intelligence Feels

Explore our full lead generation platform. No credit card. No pressure — just the fastest way to discover how Fundz can help you close smarter.

Lead iconDiscover your first AI-ranked leads — tailored to your ICP
Filter iconUse advanced filters to find promising companies
Save iconSave favorites, add notes, and preview company profiles

No credit card required. Upgrade anytime.

Free plan lets you:

  • Run up to 5 filtered searches per day
  • View up to 20 results per search
  • Explore lead scoring & tracking tools
  • Save notes and favorite companies

Trusted by teams at Google, Oracle, LinkedIn

Related People

Upgrade to Unlock

Unlock Verified Contacts + AI Outreach

Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.

Wh

Wh • Executive

Email hidden • Upgrade to unlock

Upgrade & Unlock

Trusted by teams at Google, Oracle, HubSpot & more

Upgrade to Unlock

Unlock Verified Contacts + AI Outreach

Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.

Th

Th • Executive

Email hidden • Upgrade to unlock

Upgrade & Unlock

Trusted by teams at Google, Oracle, HubSpot & more

Trends

RaisedGrowth

The data in the raised column shows reported funding for this location/industry over last 90 days.

The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days.

Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage.

https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgnew york
$4 B-20.1%
biotechnology
$8.8 B-22.7%
health care
$7.8 B-31.9%